FDA grants priority review to Roche’s Tecentriq monotherapy as first-line treatment of certain people with advanced non-small cell lung cancer

    NEXT STORY
    Ophthalmic Diagnostic Devices Market to Reach USD 3.86 Billion by 2026; Increasing Prevalence of Ocular Disorders to Boost Growth: Fortune Business Insights™
    PREV STORY
    Teleflex to Present at the Raymond James 41st Annual Institutional Investors Conference
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Progenics Pharmaceuticals to Present at the 16th Annual Needham Healthcare Conference

    NEW YORK, March 30, 2017 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (Nasdaq:PGNX), an oncology ...

    author_avatar
    NASDAQ Market News

    Ascendis Pharma A/S Announces First Quarter 2020 Financial Results and Business Update Conference Call on May 19

    author_avatar
    NASDAQ Market News

    Isopropanol Market To Reach USD 4.05 Billion By 2027 | Reports And Data

    author_avatar
    NASDAQ Market News